SLC14A1 and urinary bladder carcinoma: Mechanistic studies revealed that the SLC14A1+ subtype of CAF in bladder cancer originates from interferon-stimulated differentiation and can secrete WNT5A, thereby activating the Wnt pathway in bladder cancer cells in a paracrine manner and enhancing tumor cell stemness [18].